5,6,7,8-Tetrahydro-4h-cyclohepta[b]thiophene-3-carboxylic acid, 95%, 500mg

1-(2,2-difluoroethyl)-4-iodo-1H-pyrazole-5-carboxylic acid, 10g

(6-(1H-Pyrazol-1-yl)pyridin-3-yl)methanol, 95.0%, 250mg

(3-Bromo-4-chlorophenyl)methanamine, 95.0%, 5g

Trifluoroacetamidine, 90.0%, 25g

Benzyl (S)-(1-((4-nitrophenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate, 97%, 5g

(2S)-2-Amino-2-(oxetan-3-yl)acetic acid, 98%, 5g

Recipiente de evaporación ROTILABO® forma alta, 500 ml, 1 Pieza

(S)-(-)-Trityl glycidyl ether, 95.0%, 500g

4-Bromo-2-(((4-methoxybenzyl)oxy)methyl)-1-methylbenzene, 98%, 100mg

4-Isothiocyanatooxane, 5g

3-Chromanecarboxylic acid, 95.0%, 5g

1-Amino-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid, 98%, 5g